Complete TMF Health: Introducing LiveTMF

TransPerfect Life Sciences is proud to offer LiveTMF™, a patent-pending engine developed by Virtual Data Corp that acts as a continuous compliance layer for your electronic Trial Master File (eTMF). This first-of-its-kind solution automatically generates an expected record list that improves the study's completeness, timeliness, and quality.

Schedule a Demo
Classification, confidence quality and scoring, and metadata extraction are completed

Your Expected Record List Updates in Real Time

Every record filed in the TMF has a cause, and your TMF Plan and SOPs already define what each one requires. LiveTMF applies those rules the day the event occurs, reconfiguring expected record lists (also known as the "ERL" or "EDL") using live study data. This closes the gap between what you expect your TMF to contain and what it actually does.

1. Study Changes

A site activates, an amendment takes effect, a case is assessed as a SUSAR, or a record fulfills a placeholder.

2. Rules Apply

LiveTMF applies the rules already defined in the reference model, your TMF plan, other plans, and your policies and SOPs with the protocol as context.

3. List Updates

The ERL/EDL automatically reflects what is owed, filed, or not yet due. The reason why, with references, is also available, providing regulatory and policy justification.

Compliance, Computed: Introducing Automated EDL Management

Learn from Subject Matter Experts, Live on Dec. 10

Join the free virtual event on Thursday, December 10 at 11:00 AM ET, "Compliance, Computed: Introducing Automated EDL Management."

Speakers from Syneos Health, Virtual Data Corp, and TransPerfect Life Sciences will discuss how study teams can proactively become "inspection-steady" while reducing expected record list maintenance.

Reduce Inspection Risks with an “Inspection-Steady” eTMF

Up to 90%

less manual list management with LiveTMF, giving ClinOps teams weeks back every year and keeping the TMF inspection-ready.


Critical

grade given to a TMF that's too incomplete for inspection, as outlined in the 2026 MHRA GCP Inspection Guidance.

#2

most-cited FDA inspection observation in FY2025: inadequate or inaccurate case history records, 21 CFR 312.62(b).

12%

of critical and major GCP findings in the EMA GCP IWG 2024 report were essential document failures, the largest single category.

LiveTMF

Unlock the eTMF Time Machine

Can you explain exactly what your study owes, not just today, but on a specific date?

LiveTMF derives obligations from a study’s events and amendments and checks them against what was filed. The list recalculates and updates itself along with the rationale. You'll always be prepared to answer inspectors’ questions with an EDL that references what the study owed and what your team knew, at any point in the past.

Seamless Implementation

LiveTMF pairs perfectly with Automate for connected, AI-enabled integration into the clinical trial's existing systems. Clinical operation experts from TransPerfect Life Sciences and the Syneos Health R&D Advisory work together to translate the technology capabilities of Automate and LiveTMF into sponsor-specific solutions through project delivery oversight, SOP assessment, rule configuration, validation execution, and change management

  • Icon ai portal
  • Your eTMF

    LiveTMF reads the eTMF without changing anything about how sites and CROs file records or requiring additional software.

  • Icon R&D
  • Your Rules

    Automation is configured according to your TMF and SOPs and managed under your change-control procedures.

  • Icon quality
  • Built for Validation

    Designed to support GAMP 5, 21 CFR Part 11 and Annex 11 requirements, with ALCOA+ audit trails.

    Ready to transform your study's EDL?

    LiveTMF adds a continuous compliance layer that sits directly on top of your eTMF, so you’ll never have to worry about outdated expected record lists again.

    Schedule a demo today to see LiveTMF in action.

    How did you hear about us?
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    How to Select the Right Regulatory Writing Company for Your Organization's Needs

    In a landscape defined by ever-evolving global guidelines from health authorities, many life sciences organizations’ clinical and regulatory teams face challenges in navigating the regulatory affairs writing and document submission process. Adhering to strict rules while balancing the concerns of multiple stakeholders, timelines, and costs can be a profoundly complex undertaking in this high-stakes environment. To successfully expand their products globally and ...

    How to Select the Right Regulatory Writing Company for Your Organization's Needs

    Governing AI for Global Content in the Life Sciences Industry

    AI is already shaping the content that reaches patients, healthcare professionals, and regulators, often through tools that were never built for regulated use. But adoption alone doesn’t create control, and a single terminology error or untraceable approval can put compliance and ...

    MDR SSCPs and IVDR SSPs Are NOT Labeling: What That Means for Your EUDAMED Upload

    As soon as possible, but no later than March 27, 2027 (per MDCG 2026-4), medical device manufacturers must upload their validated, translated Summaries of Safety and Clinical Performance (SSCPs) to EUDAMED themselves. IVD manufacturers have the same responsibility for their...

    Reddit Stories: AI Failures in Clinical Trials

    Clinical operations experts react to real AI failure stories pulled directly from Reddit and work backward to identify what should have caught them. From hallucinated citations that passed an initial review to AI-drafted guidance sent to a site without proper oversight, each ...

    Are Legacy COA Instruments Still Fit for Purpose?

    The following insights are synthesized from TransPerfect LifeSci Talks, hosted by Mark P. Wade, Practice Leader COA SME at TransPerfect Life Sciences, with guest Kathrin Fischer, PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and board member of ISOQOL....

    The Human in the Vault: Building Review Workflows That Satisfy Regulators

    AI translation is already fast enough for most teams. The gap is on the review side: who signs off, what gets logged, and whether the process holds up when a regulator asks. This session walks through a real human review workflow within an AI-assisted translation process ...

    eConsent: Why the Content Matters as Much as the Tech

    Insights from a conversation with Edwin Cohen, Principal Consultant / Owner at C&Flow Instrument Creation and Mark P Wade Global Practice Leader & COA SME, TransPerfect Life Sciences For all the attention paid to the systems, platforms, and integrations behind...